Stockscreener 앱 받기
1.56
2.50%
-0.04
Calcimedica Inc 주식(CALC)의 최신 뉴스
CalciMedica Insiders Added US$1.05m Of Stock To Their Holdings - Yahoo Finance
CalciMedica's Breakthrough AKI Treatment Takes Center Stage at Prestigious Vicenza Nephrology Conference - Stock Titan
Millennium Management LLC Acquires 16,824 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World
calcimedica appoints baker tilly as new accounting firm after merger By Investing.com - Investing.com South Africa
calcimedica appoints baker tilly as new accounting firm after merger - Investing.com
HC Wainwright Reiterates “Buy” Rating for CalciMedica (NASDAQ:CALC) - Defense World
CalciMedica (CALC) Receives Reiteration of Buy Rating with $16 P - GuruFocus
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune
CalciMedica (CALC) Expected to Announce Quarterly Earnings on Monday - Defense World
CalciMedica Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Renaissance Technologies LLC Purchases New Stake in CalciMedica, Inc. (NASDAQ:CALC) - Defense World
Geode Capital Management LLC Boosts Stock Holdings in CalciMedica, Inc. (NASDAQ:CALC) - Defense World
Bristol-Myers Squibb (NYSE:BMY) vs. CalciMedica (NASDAQ:CALC) Critical Review - Defense World
CalciMedica (NASDAQ:CALC) Shares Up 0.7% – Here’s Why - Defense World
CalciMedica's Breakthrough Research Takes Center Stage at Two Elite Medical Conferences - Stock Titan
CalciMedica Announces Presentations at Upcoming Medical Meetings - PR Newswire
Analysts Offer Predictions for CalciMedica Q4 Earnings - Defense World
CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance
Corient Private Wealth LLC Buys New Shares in CalciMedica, Inc. (NASDAQ:CALC) - Defense World
CalciMedica (NASDAQ:CALC) Receives “Buy” Rating from HC Wainwright - Defense World
Corient Private Wealth LLC Acquires Shares of 38,000 CalciMedica, Inc. (NASDAQ:CALC) - The AM Reporter
Graybug Vision stock hits 52-week low at $1.81 - Investing.com India
Graybug Vision stock hits 52-week low at $1.81 By Investing.com - Investing.com South Africa
H.C. Wainwright maintains $16 target on CalciMedica stock - Investing.com Australia
CalciMedica’s Strong Financial Position and Promising Clinical Pipeline Justify Buy Rating - TipRanks
CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference - PR Newswire
CalciMedica says cash sufficient to fund operating plan into mid-2026 - TipRanks
CALCIMEDICA Earnings Results: $CALC Reports Quarterly Earnings - Nasdaq
CalciMedica Inc reports results for the quarter ended December 31Earnings Summary - TradingView
CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune
Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates - MarketScreener
CalciMedica (CALC) to Release Earnings on Thursday - The AM Reporter
CalciMedica Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Atria Investments Inc Buys 7,509 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World
CalciMedica (CALC) Expected to Announce Quarterly Earnings on Thursday - Defense World
Graybug Vision stock hits 52-week low at $1.83 amid challenges - Investing.com
Rani Therapeutics (NASDAQ:RANI) versus CalciMedica (NASDAQ:CALC) Financial Contrast - Defense World
Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora - TipRanks
Short Interest in CalciMedica, Inc. (NASDAQ:CALC) Increases By 35.0% - Defense World
Latham & Watkins Advises CalciMedica in Secured Growth Financing - Latham & Watkins LLP
CalciMedica secures $32.5 million credit facility By Investing.com - Investing.com Canada
CalciMedica secures credit facility for up to $32.5M - MSN
CalciMedica Secures Credit Facility For Up To $32.5 Million -March 05, 2025 at 07:44 am EST - Marketscreener.com
CalciMedica secures $32.5 million credit facility - Investing.com India
CalciMedica Secures Credit Facility for Up to $32.5 Million - Finansavisen
CalciMedica (NASDAQ:CALC) Given “Buy” Rating at HC Wainwright - Defense World
Graybug Vision stock hits 52-week low at $1.95 amid challenges - Investing.com
CalciMedica reports reduced mortality in AKI trial with Auxora - Investing.com
CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment - TipRanks
CalciMedica reports reduced mortality in AKI trial with Auxora By Investing.com - Investing.com South Africa
CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial - TipRanks
CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference - PR Newswire
0.39%
0.42%
자본화:
|
볼륨(24시간):